South Korea · Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 217.35 billion. The enterprise value is 339.85 billion.
| Market Cap | 217.35B |
| Enterprise Value | 339.85B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 9, 2026 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -1.44% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -1.44% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 5.77% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 6.51 and the forward PE ratio is 5.16.
| PE Ratio | 6.51 |
| Forward PE | 5.16 |
| PS Ratio | 0.44 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 6.69 |
| P/FCF Ratio | 7.91 |
| P/OCF Ratio | 6.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.91, with an EV/FCF ratio of 12.36.
| EV / Earnings | 10.17 |
| EV / Sales | 0.69 |
| EV / EBITDA | 5.91 |
| EV / EBIT | 6.92 |
| EV / FCF | 12.36 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 1.36.
| Current Ratio | 1.23 |
| Quick Ratio | 0.64 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | 2.85 |
| Debt / FCF | 5.95 |
| Interest Coverage | 7.39 |
Financial Efficiency
Return on equity (ROE) is 33.76% and return on invested capital (ROIC) is 16.90%.
| Return on Equity (ROE) | 33.76% |
| Return on Assets (ROA) | 9.11% |
| Return on Invested Capital (ROIC) | 16.90% |
| Return on Capital Employed (ROCE) | 24.04% |
| Weighted Average Cost of Capital (WACC) | 5.73% |
| Revenue Per Employee | 3.72B |
| Profits Per Employee | 253.14M |
| Employee Count | 132 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 5.63 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 11.19 billion in taxes.
| Income Tax | 11.19B |
| Effective Tax Rate | 24.14% |
Stock Price Statistics
The stock price has increased by +26.35% in the last 52 weeks. The beta is 0.63, so EASY BIO,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +26.35% |
| 50-Day Moving Average | 7,266.80 |
| 200-Day Moving Average | 6,543.20 |
| Relative Strength Index (RSI) | 44.57 |
| Average Volume (20 Days) | 199,058 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 490.70 billion and earned 33.41 billion in profits. Earnings per share was 1,009.60.
| Revenue | 490.70B |
| Gross Profit | 128.62B |
| Operating Income | 49.10B |
| Pretax Income | 46.36B |
| Net Income | 33.41B |
| EBITDA | 57.46B |
| EBIT | 49.10B |
| Earnings Per Share (EPS) | 1,009.60 |
Balance Sheet
The company has 46.96 billion in cash and 163.68 billion in debt, with a net cash position of -116.71 billion or -3,528.04 per share.
| Cash & Cash Equivalents | 46.96B |
| Total Debt | 163.68B |
| Net Cash | -116.71B |
| Net Cash Per Share | -3,528.04 |
| Equity (Book Value) | 120.30B |
| Book Value Per Share | 3,459.48 |
| Working Capital | 36.32B |
Cash Flow
In the last 12 months, operating cash flow was 35.05 billion and capital expenditures -7.56 billion, giving a free cash flow of 27.49 billion.
| Operating Cash Flow | 35.05B |
| Capital Expenditures | -7.56B |
| Depreciation & Amortization | 8.36B |
| Net Borrowing | -1.80B |
| Free Cash Flow | 27.49B |
| FCF Per Share | 831.09 |
Margins
Gross margin is 26.21%, with operating and profit margins of 10.01% and 6.81%.
| Gross Margin | 26.21% |
| Operating Margin | 10.01% |
| Pretax Margin | 9.45% |
| Profit Margin | 6.81% |
| EBITDA Margin | 11.71% |
| EBIT Margin | 10.01% |
| FCF Margin | 5.60% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 3.80%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 3.80% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 20.62% |
| Buyback Yield | 1.44% |
| Shareholder Yield | 5.66% |
| Earnings Yield | 15.37% |
| FCF Yield | 12.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.73 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.73 |
| Piotroski F-Score | 6 |